EFTR - eFFECTOR Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts4444
Avg. Estimate-0.2-0.18-0.77-0.97
Low Estimate-0.26-0.31-1.14-1.48
High Estimate-0.17-0.1-0.53-0.53
Year Ago EPS-0.17-0.23-0.55-0.77
Revenue EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts3333
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago Sales2.01M867k3.55MN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20229/29/202212/30/20223/30/2023
EPS Est.-0.16-0.21-0.24-0.14
EPS Actual-0.17-0.23-0.22-0.24
Difference-0.01-0.020.02-0.1
Surprise %-6.30%-9.50%8.30%-71.40%
EPS TrendCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Current Estimate-0.2-0.18-0.77-0.97
7 Days Ago-0.2-0.18-0.77-0.97
30 Days Ago-0.2-0.16-0.77-0.92
60 Days Ago-0.21-0.17-0.78-0.87
90 Days Ago-0.22-0.21-0.69-1.01
EPS RevisionsCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1231
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesEFTRIndustrySector(s)S&P 500
Current Qtr.-17.60%N/AN/AN/A
Next Qtr.21.70%N/AN/AN/A
Current Year-40.00%N/AN/AN/A
Next Year-26.00%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A